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Abstract
Treating the elderly is often problematic, especially when congenital heart
disease is diagnosed. The aim of this study is to present the case of a 72-year
old woman with depression syndrome, paroxysmal atrial fibrillation and past
cerebral stroke, in whom persistent ductus arteriosus Botalli was diagnosed.
Due to exacerbation of the depressive syndrome, she did not give her consent
to further diagnostics, possible interventional procedures and treatment with
oral anticoagulants. After intermission of the therapy she was treated with
dabigatran. The patient is still undergoing outpatient treatment and so far, no
cerebrovascular episodes have been recorded. 
Key words: atrial fibrillation, persistent ductus arteriosus Botalli, patent foramen
ovale, elderly people, dabigatran.
Introduction
Persistent ductus arteriosus Botalli (PDA) in patients over 65 years old
is a rare finding. According to the medical literature, two of the oldest
patients in whom PDA has been diagnosed are a 92-year-old Japanese
woman [1] and a 90-year-old man from the USA [2].
The frequency of PDA, which is a quite frequent (15-20%) congenital
heart failure in children, has increased in the last two decades. It is caused
by a higher survival rate of premature babies [3]. It is reported that rubella
virus infection in the first pregnancy trimester accounts for the occurrence
of PDA [4].
During the intrauterine life, the ductus arteriosus connects the
descending aorta with the left pulmonary artery. After birth, the flow
reverses and functional occlusion of the ductus arteriosus occurs. In the
majority of infants, the ductus is obliterated during the first month. The
PDA leads to a left-to-right shunt of varying intensity.
The main symptoms of PDA are dyspnoea, diminished effort tolerance,
and Gibson’s machine murmur. Small shunts usually give no symptoms
for a long time and they are diagnosed accidentally. Large shunts lead to
pulmonary hypertension and the development of Eisenmenger syndrome.
The main PDA diagnostic examination is echocardiography, but also
Corresponding author:
Adam Rafał Poliwczak MD, PhD
Department of Internal Diseases
and Clinical Pharmacology
Medical University of Lodz
1/5 Kniaziewicza 
91-347 Lodz, Poland
Phone: +48 42 651 10 59
Fax: +48 42 651 10 59
E-mail:
adam.poliwczak@umed.lodz.pl
Case report
1Department of Internal Diseases and Clinical Pharmacology, Medical University 
of Lodz, Poland
2Department of Cardiology, Medical University of Lodz, Poland
Submitted: 6 August 2010
Accepted: 3 October 2010
Arch Med Sci 2011; 7, 5: 914-917
DOI: 10.5114/aoms.2011.25572  
Copyright © 2011 Termedia & BanachArch Med Sci 5, October / 2011 915
computed tomography (CT) and magnetic reso  -
nance imaging (MRI) [5]. The final PDA evaluation
is made during angiography [4].
The PDA is treated via a thoraco- or sternotomy
occlusion. Percutaneous interventional occlusion by
unfastened coil or Amplatzer occluder are currently
more and more frequent reference techniques 
[6, 7]. About 20% of non-treated PDA patients die
before reaching the age of 30 [8]. 
Case report
We would like to present the case of a 72-year-
old woman suffering from PDA, with patent
foramen ovale (PFO), past cerebral stroke and
depression syndrome.
The 72-year-old woman was sent to the
cardiology outpatient clinic because of recurring
episodes of paroxysmal atrial fibrillation (AF), and
symptoms of heart failure (NYHA II, periodically
NYHA III). As the anamnesis and medical history of
the patient revealed, in the past year, 3 or 4
episodes of paroxysmal AF occurred, and for that
reason she was twice admitted to hospital and
treated in the internal medicine ward. In that time
she had cerebral stroke with left-side hemiparesis,
moderate aphasia and intermittent bulbar syn  dro  -
me (the presence of a cerebral ischaemic focal
lesion was confirmed by CT examination). In echo  -
cardio  graphy recently performed on an outpatient
clinic basis, haemodynamically signi  ficant PDA was
demonstrated. The patient was also treated for
hypertension, chronic obstructive pulmonary
disease (COPD) and mixed depressive-anxiety
disorders. She also underwent strumectomy due to
neutral nodular goitre. It was likely that the patient
had haemodynamically significant PDA so she was
sent to the Department of Internal Diseases with
Clinical Pharmacology for further evaluation of 
the heart defect and possible qualification for
percutaneous PDA occlusion. On admission to the
hospital the physical examination revealed the
presence of bilateral crepitant rales at the base of
the lungs and prolonged exhale phase. Heart action
was regular (64/min). Her arterial blood pressure
was 140/80 mmHg, BMI 22.5 kg/m2. On the left
margin of the sternum there was quiet systolic
murmur (loudness 1/6 by Levin) with no Gibson’s
machine murmur typical for PDA. Before admission
to the department, the patient was treated with
clopidogrel, simvastatin, perindopril, metoprolol,
levothyroxine, fluticasone/salmeterol, diazepam,
estazolam and levomepromazine. Serum plasma
investigation and urinalysis did not reveal any
abnormalities. ECG: levogram. Sinus regular rhythm
64/min, small progression of r wave in precordial
leads V1-V4, inverted T wave in V1-V2, QTc 420 ms.
Transthoracic echocardiography revealed the
following findings: LVEDD 52 mm, LVESD 34 mm,
LA 45 mm, RA 32 mm, PA 35 mm, RVEDD 28 mm,
Ao ASC 28 mm, IVSd 10 mm, IVSs 13 mm, PWd 
10 mm, PWs 13 mm, SPAP 32 mmHg; besides trace
of mitral and tricuspid insufficiency, no other flow
perturbations or organic changes of the valvular
leaflets were found; left ventricle (LV) impaired
relaxation, LV symmetric contractility, ejection
fraction EF = 62%, TAPSE 24 mm. A left to right
shunt between the descending aorta and left
pulmonary artery, on the basis of PDA with the
diameter circa 8 mm, was found (Figures 1 and 2).
On Doppler examination the systolic-diastolic flow
was present, Vmax 2.5 m/s. No pulmonary hyper  -
tension occurred. The pulmonary trunk was signi  -
ficantly dilated. A slightly protruded atrial septum
with small PFO (3 mm) and small left to right shunt
was found (Figure 3).
According to current ESC and ACC/AHA
recommendations [7, 9] PDA is regarded as 
significant when the following are found: LV and/or
LA dilatation, LV volume overload, pulmonary
hypertension and associated lesions which may occur
in PDA. Although the PDA had excessive diameter 
(ca. 8 mm), there was no evidence of clinical or
haemodynamic significance. The LV dilatation, 
Figure 1. Transthoracic two-dimensional echocardio  graphy (panel A) and three-dimensional echo  cardiography 
(panel B). Modified parasternal view with colour Doppler flow mapping reveals presence of turbulent flow (arrow)
in dilated pulmonary artery (PA) indicative of left-to-right shunt through patent ductus arteriosus
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LV volume overload and pulmonary hypertension
were not observed. Qp : Qs index was 1.3. No other
lesions associated with PDA were observed. Only
LA diameter was enlarged (45 mm). The small PFO
seemed to be of no haemodynamic significance
either. Presumably, due to the exacerbation of
depressive syndrome, the patient did not give her
consent to further diagnostic procedures and
possible interventional occlusion. For that reason
no further examinations were performed. The lack
of haemodynamic significance of PDA and PFO
justified the chosen course of treatment. The
patient was treated with vitamin K antagonist (VKA)
(recommended INR value was achieved) and
infectious endocarditis prophylaxis was applied. The
general condition of the patient improved, and no
episodes of paroxysmal atrial fibrillation occurred.
Discharge recommendations included VKA
(acenocoumarol). After 3 weeks of treatment, the
patient refused to continue VKA therapy and with
no medical consultation she switched to clopidogrel
instead. The reason she provided was that she
could not accept regular INR blood tests. During an
appointment in the outpatient clinic, she was
suggested dabigatran therapy 110 mg twice a day,
which she accepted. The patient has been
monitored cardiologically for 6 months now.
Moreover, she has been under the supervision of
a psychiatric outpatient clinic too. In that period no
heart failure exacerbation, atrial fibrillation or
cerebral ischaemic episodes occurred. 
Discussion
According to the current recommendations,
a haemodynamically significant PDA, with typical
Gibson’s machine murmur, should be occluded 
[7, 9]. Percutaneous procedures are preferred, but
the type of the procedure depends on the PDA
diameter and the experience of the scientific staff
[5]. Coexistence of other heart or great vessel
pathologies may also affect the occlusion method
selection. In a case of small PDA of no haemo  -
dynamic significance, which can be found only by
medical imaging examination, therapeutic
management is not so obvious. In these situations
many factors, such as the patient’s preferences,
concomitant diseases, and possible complications
of a procedure, should be considered. Life expec  -
tancy seems to be an important aspect too. In any
case, an individual approach is recommended. There
is an additional problem referring to elderly people,
who often do not understand the necessity of
therapy. In the presented case, besides the somatic
diseases, the patient suffered from a depressive
syndrome. There was a risk that the exacerbation
of this syndrome could lead to non-compliance, and
indeed, this was the case. After echocardiographic
examination, the patient did not give her consent
to further diagnostic and therapeutic procedures.
Because of the cerebral stroke history and recurring
episodes of paroxysmal atrial fibrillation, we used
the CHADS2 scale to estimate the thromboembolic
risk. The CHADS2 score was 4 points, which
indicated high thromboembolic risk. The VKA was
administered and the appropriate INR level was
achieved [10]. Unfortunately, the patient’s non-
compliance and her wilful discontinuance of
anticoagulant therapy created a high risk of further
thromboembolic episodes. According to the recently
published RE-LY trial, we decided to administer
dabigatran (Pradaxa®) [11]. The exacerbation of the
depressive syndrome was partly handled by higher
doses of antidepressants, although this increased
the risk of drug interactions. 
In conclusion, therapy of the elderly is often
problematic [12, 13]. This refers to both management
Figure 2. Transthoracic echocardiography with pulsed
wave Doppler technique confirms presence of
continuous left-to-right shunt through patent ductus
arteriosus
Figure 3. Transthoracic two-dimensional echocardio  -
graphy. Subcostal view with colour Doppler flow
mapping indicates presence of small left-to-right
shunt (arrow) through patent foramen ovale
LA – left atrium, RA – right atrium, LV – left ventricle, 
RV – right ventricle
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of common pathologies and congenital heart
defects found in the elderly. The appropriate
medical treatment is not always accepted by the
patient, who does not give his consent or does not
understand the aim of therapy. In the reported case,
the patient did not consent to PDA occlusion and
VKA treatment, and therefore conservative therapy,
including dabigatran, a new anticoagulation drug,
was applied. The effects of this 6-month-long
therapy have been satisfactory so far.
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